A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants

Clinical trial NCT06308523 · COMPLETED

Trial details

NCT number: NCT06308523
Sponsor: Alebund Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-03-18
Primary completion: 2024-05-13
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.